Abstract

Are We Getting the Best Return on Investment From Clinical Drug-Drug Interaction Studies?

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Development of best practices in physiologically based pharmacokinetic modeling to support clinical pharmacology regulatory decision-making-A workshop summary.
Daphney Jean ...
CPT: Pharmacometrics & Systems Pharmacology | VOL. 10
Daphney Jean, et. al.Daphney Jean ...
18 Sep 2021
Participation of hypertension patients in early-phase clinical trials.
Paul Borron ... Theo J Hoofwijk
Journal of clinical hypertension (Greenwich, Conn.) | VOL. 16
Paul Borron, et. al.Paul Borron ... Theo J Hoofwijk
22 Apr 2014
AB1064 No clinically meaningful drug interactions expected between lesinurad, a novel oral uricosuric agent, and drugs most commonly used by gout patients
...
Annals of the Rheumatic Diseases | VOL. 71
, et. al. ...
01 Jun 2013
What Can Be Learned from Recent New Drug Applications? A Systematic Review of Drug Interaction Data for Drugs Approved by the US FDA in 2015.
Jingjing Yu ... Zhu Zhou
Drug Metabolism and Disposition | VOL. 45
Jingjing Yu, et. al.Jingjing Yu ... Zhu Zhou
07 Nov 2016
View more papers

More From: Journal of clinical pharmacology

Paper Title
Journal
Date
Author
Driving Efficiency: Leveraging Model-Informed Approaches in 505(b)(2) Regulatory Actions.
Vishnu Dutt Sharma ... Hao Zhu
Journal of clinical pharmacology | VOL. -
Vishnu Dutt Sharma, et. al.Vishnu Dutt Sharma ... Hao Zhu
09 Aug 2024
Pharmacokinetics of Dexamethasone in Children and Adolescents with Obesity.
Jiali Wen ...
Journal of clinical pharmacology | VOL. -
Jiali Wen, et. al.Jiali Wen ...
09 Aug 2024
Predict the Drug-Drug Interaction of a Novel PI3Kα/δ Inhibitor, TQ-B3525, and Its Two Metabolites Using Physiologically Based Pharmacokinetic Modeling.
Shixing Zhu ... Xin Wang
Journal of clinical pharmacology | VOL. -
Shixing Zhu, et. al.Shixing Zhu ... Xin Wang
06 Aug 2024
Safety, Tolerability, and Pharmacokinetics of Single Doses of Exidavnemab (BAN0805), an Anti-α-Synuclein Antibody, in Healthy Western, Caucasian, Japanese, and Han Chinese Adults.
Emma Boström ... Tomas Odergren
Journal of clinical pharmacology | VOL. -
Emma Boström, et. al.Emma Boström ... Tomas Odergren
06 Aug 2024
View more papers